Ales Bartl

Ales Bartl, Ph.D., advises raw material suppliers, product manufacturers, and trade associations on EU product regulatory law. He focuses on REACH and CLP regulations; Biocidal and Plant Protection Products Regulations; as well as sector-specific regulations relating to electronic products, medical devices, and other CE-marked products, cosmetics, electronic cigarettes, and novel nicotine products. Ales also advises on EU sustainability regulations, including deforestation, CBAM, green claims, and general product compliance and product safety. Ales represents clients before EU and national competent authorities on compliance and enforcement issues, including product withdrawals and recalls. 

Ales also represents clients before the Court of Justice of the European Union and the Board of Appeal of European Chemicals Agency.

Prior to joining Keller and Heckman in 2020, Ales interned at the European Commission (EC) and worked for almost ten years as an EU regulatory associate at international law firms in Brussels.

Representative Matters

• Regularly advised on PFAS restrictions under REACH and PPWR, including representation in public consultations and advocacy work
• Advised on recent sustainability regulations, including Sustainability Reporting and Due Diligence, Deforestation, CBAM, Plastic Pellet Losses, etc. 
• Advised on certification of sustainability labels and green claims under the new EmpCo Directive    
• Represented a client in a legal challenge to the listing of a substance as a Substance of Very High Concern (SVHC) in the EU General Court
• Represented a trade association in an appeal of a REACH Restriction before the European Court of Justice
• Represented a client in challenging dossier evaluation decisions before the ECHA Board of Appeal
• Represented clients in several substance and dossier evaluation procedures before ECHA
• Advised on applicability of new hazard classes under CLP Regulation (PBT/vPvB, endocrine disruptors)
• Advised on harmonized classification and labeling procedures, including advocacy with ECHA’s Committees and the European Commission 
• Advised on withdrawal of a consumer product containing REACH-restricted phthalates
• Provided advocacy related to a derogation request from a REACH restriction
• Drafted data-sharing agreements related to new biocidal active substances and biocidal product families
• Provided assessments of the regulatory status of several borderline products between medical device/cosmetic products/biocidal products
• Conducted data-sharing disputes
• Advised on the best pathways for authorization of biocidal products
• Provided defense of a Biocidal Products Regulation (BPR) enforcement case in France
• Advised on Restriction of Hazardous Substances (RoHS) (applicability, exemption procedures, interface with REACH)